Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Celtaxsys
AddedFeb 15, 2024
UpdatedJun 18, 2026
Celtaxsys

Celtaxsys

Public

Celtaxsys Inc., a biopharmaceutical firm, develops drugs for inflammatory and autoimmune diseases.

HQ
Atlanta, GA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Celtaxsys Inc., founded with the mission to transform the treatment landscape for inflammatory and autoimmune diseases, is a biopharmaceutical company dedicated to the research, development, and commercialization of innovative pharmaceutical products. The company's core focus is on creating therapies that address significant unmet medical needs, particularly in conditions like cystic fibrosis and other chronic inflammatory diseases. Celtaxsys aims to improve patient outcomes through targeted drug development, leveraging advanced scientific research and clinical trials.

Notable figures associated with Celtaxsys include experienced industry leaders and scientists who bring a wealth of expertise in drug development and commercialization. The company has attracted investment from prominent venture capital firms and has achieved key milestones, including successful clinical trials and regulatory advancements. Celtaxsys' impact is marked by its commitment to advancing medical science and providing new hope for patients suffering from debilitating inflammatory and autoimmune conditions.

Celtaxsys - Similar Companies

Cellix Bio logo

Cellix Bio

Complexa logo

Complexa

Celnyx logo

Celnyx

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

cystetic Medicines logo

cystetic Medicines

Exalys Therapeutics logo

Exalys Therapeutics

Virxsys logo

Virxsys

Celmatix logo

Celmatix

celmatix.com

Synspira logo

Synspira

SeaStar Medical logo

SeaStar Medical

Sequella logo

Sequella

Aristea Therapeutics logo

Aristea Therapeutics

CytoAgents logo

CytoAgents

cytoagents.com

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Panacela Labs logo

Panacela Labs

panacelalabs.com

Celtaxsys - Quick Facts

Who are Celtaxsys' competitors?

Companies similar to Celtaxsys include Cellix Bio, Complexa, Celnyx and Celsius Therapeutics.

When was Celtaxsys founded?

Celtaxsys was founded in 2007.

Where is Celtaxsys' headquarters located?

Celtaxsys' headquarters is located in Atlanta, GA, US.

When was Celtaxsys' last funding round?

Celtaxsys' most recent funding round was for $5M (USD) in March 2019.

How much has Celtaxsys raised to-date?

As of Mar 19, 2019, Celtaxsys has raised a total of $65.2M (USD).

How many employees does Celtaxsys have?

Celtaxsys has 11 employees as of Feb 5, 2024.

Celtaxsys - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 8690Other human health activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified